201 related articles for article (PubMed ID: 22975107)
1. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.
Wu LM; Diefenbach MA; Gordon WA; Cantor JB; Cherrier MM
Urol Oncol; 2013 Nov; 31(8):1533-8. PubMed ID: 22975107
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
[TBL] [Abstract][Full Text] [Related]
3. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
4. Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study.
Wu LM; Amidi A; Tanenbaum ML; Winkel G; Gordon WA; Hall SJ; Bovbjerg K; Diefenbach MA
Support Care Cancer; 2018 Jun; 26(6):1917-1926. PubMed ID: 29282534
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
[TBL] [Abstract][Full Text] [Related]
6. Cognitive effects of hormone therapy in men with prostate cancer: a review.
Nelson CJ; Lee JS; Gamboa MC; Roth AJ
Cancer; 2008 Sep; 113(5):1097-106. PubMed ID: 18666210
[TBL] [Abstract][Full Text] [Related]
7. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
[TBL] [Abstract][Full Text] [Related]
8. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis.
Chao HH; Uchio E; Zhang S; Hu S; Bednarski SR; Luo X; Rose M; Concato J; Li CS
BMC Cancer; 2012 Aug; 12():371. PubMed ID: 22925152
[TBL] [Abstract][Full Text] [Related]
9. Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.
Kluger J; Roy A; Chao HH
Curr Oncol Rep; 2020 Feb; 22(3):24. PubMed ID: 32048059
[TBL] [Abstract][Full Text] [Related]
10. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study.
Chao HH; Hu S; Ide JS; Uchio E; Zhang S; Rose M; Concato J; Li CS
PLoS One; 2013; 8(8):e72032. PubMed ID: 23977199
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings.
Hoogland AI; Jim HSL; Gonzalez BD; Small BJ; Gilvary D; Breen EC; Bower JE; Fishman M; Zachariah B; Jacobsen PB
Cancer; 2021 May; 127(9):1476-1482. PubMed ID: 33378113
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
[TBL] [Abstract][Full Text] [Related]
13. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
[TBL] [Abstract][Full Text] [Related]
14. Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy: A cross-sectional study.
Yang J; Zhong F; Qiu J; Wang K
Asia Pac J Clin Oncol; 2015 Dec; 11(4):277-81. PubMed ID: 25856786
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Leslie WD; Lau YK
BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
[TBL] [Abstract][Full Text] [Related]
17. Contemporary role of androgen deprivation therapy for prostate cancer.
Pagliarulo V; Bracarda S; Eisenberger MA; Mottet N; Schröder FH; Sternberg CN; Studer UE
Eur Urol; 2012 Jan; 61(1):11-25. PubMed ID: 21871711
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.
Cherrier MM; Aubin S; Higano CS
Psychooncology; 2009 Mar; 18(3):237-47. PubMed ID: 18636420
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.
Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE
Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290
[TBL] [Abstract][Full Text] [Related]
20. Impact of Androgen Deprivation Therapy on Self-Reported Cognitive Function in Men with Prostate Cancer.
Marzouk S; Naglie G; Tomlinson G; Duff Canning S; Breunis H; Timilshina N; Alibhai SMH
J Urol; 2018 Aug; 200(2):327-334. PubMed ID: 29477720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
